Trade iBio, Inc. - IBIO CFD

Trading Conditions

• Type: CFD
• Spread: 0.0926
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 2.4937
• Open: 2.5537
• 1-Year Change: -53.88%
• Day's Range: 2.3537 - 2.6637

What is iBio, Inc. (IBIO)?

iBio, Inc. is a biotechnology company focused on developing and manufacturing biopharmaceuticals and vaccines using plant-based technologies. The company employs proprietary platforms to produce proteins and other biologics in plant cells, offering an alternative to traditional cell culture methods. iBio's approach aims to enhance the speed, scalability, and cost-effectiveness of biomanufacturing. Its pipeline includes therapeutic candidates for infectious diseases and other medical conditions. The company operates within the broader biopharmaceutical industry, emphasizing innovation in biologics production.

iBio, Inc. Stock Price Today: Live Overview

The price today is shaped by trading momentum, with iBio, Inc. valued at $2.5163. It has experienced intraday movement between $2.3537 and $2.6937, reflecting a daily change of 0%.

FAQ: iBio, Inc. (IBIO)

What is the current price of IBIO stock?

The latest trading price is $2.5163.

Does IBIO pay dividends?

iBio, Inc. does not pay dividends.

Does IBIO have a formal corporate presence or regional headquarters in the UAE?

iBio, Inc. operates in the UAE through partners and distributors without an official regional office or subsidiary.

What is IBIO best known for?

The company is most famous for its development of plant-based biopharmaceuticals.

What assets are typically shown together with IBIO?

Commonly shown alongside IBIO: SIGA Tech, Surge Energy Inc, Eli Lilly & Co